Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Press Release

60% agree that no Brexit is better than ‘no deal’ Brexit

Following today’s news (19 December 2018) that the EU is implementing a ‘no deal’ Brexit plan, Alexandra Annis, Pharma analyst at GlobalData offers her view: “This news does not come as a surprise as 38% of respondents from GlobalData’s recent report ‘Brexit and the Healthcare Industry – Implications for Pharma, Q3 2018’ indicated a ‘no […]
Read more

Treponema Pallidum Tests global market to reach $462m by 2028

The global Treponema Pallidum (or Syphilis) Tests market is projected to reach $462m by 2028, growing at a Compound Annual Growth Rate (CAGR) of 2.99% between 2018 and 2028, according to GlobalData, a leading data and analytics company. The company’s latest report, ‘Treponema Pallidum Tests’ reveals that North America and Asia Pacific will be the […]
Read more

For Amgen’s infliximab biosimilar to succeed, a sound strategy is needed to differentiate ABP-710 from competitors

Following the announcement of Amgen’s submission of a biologics license application (BLA) for its infliximab biosimilar candidate, ABP-710, Rose Joachim, Pharma Analyst at GlobalData, a leading data and analytics company, offers her view on the future prospects of ABP-710, if approved in the US: “Considering that Amgen will not be able to launch its adalimumab […]
Read more

Aortic stent graft global market to reach $4.5bn by 2028

The global aortic stent graft market is expected to reach $4.5bn by 2028, growing at a Compound Annual Growth Rate (CAGR) of 5.4% between 2018 and 2028, according to GlobalData, a leading data and analytics company. The company’s latest report, ‘Aortic Stent Grafts’ reveals that Asia Pacific will be one of the fastest growing regions […]
Read more

Stelara shows excellent efficacy and safety in Crohn’s but its future in the UC market remains uncertain

Following the announcement of positive results from Janssen’s Phase III open label long- term extension study, which evaluates the efficacy and safety data of Stelara in Crohn’s Disease (CD), Patrick Aiyes, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view on Stelara’s future prospects in the Inflammatory Bowel Disease (IBD) market: […]
Read more

Implantable Cardioverter Defibrillator (ICD) market expected to reach $4.3bn by 2028, says GlobalData

The Implantable Cardioverter defibrillator (ICD) market is expected to reach approximately $4.3bn by 2028, growing at a Compound Annual Growth Rate (CAGR) of 4.1%, according to GlobalData, a leading data and analytics company. The company’s latest report: ‘Implantable Cardioverter Defibrillator (ICD) Devices – Cardiovascular Market Analysis and Forecast Model’ states that Asia Pacific will be […]
Read more

Competition in Multiple Sclerosis market set to increase with launch of new pipeline drugs and entry of new generics

The Multiple Sclerosis (MS) therapeutics market has entered an exciting phase, with an upsurge of available treatment options and several promising late-stage pipeline products offering diverse mechanisms of action (MOAs). The launch of 12 new therapies will drive growth in the MS space, provide more options for patients, and stimulate further competition, says GlobalData, a leading data and analytics company.
Read more
1 … 39 40 41 42 43 … 61